0001171000-15-000112.txt : 20151124
0001171000-15-000112.hdr.sgml : 20151124
20151124161914
ACCESSION NUMBER: 0001171000-15-000112
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151123
FILED AS OF DATE: 20151124
DATE AS OF CHANGE: 20151124
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nexvet Biopharma plc
CENTRAL INDEX KEY: 0001618561
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK
STREET 2: RAHAN ROAD
CITY: TULLAMORE , CO. OFFALY
STATE: L2
ZIP: R35 FR98
BUSINESS PHONE: 353 1 215 8100
MAIL ADDRESS:
STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK
STREET 2: RAHAN ROAD
CITY: TULLAMORE , CO. OFFALY
STATE: L2
ZIP: R35 FR98
FORMER COMPANY:
FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd
DATE OF NAME CHANGE: 20140903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farrell Geraldine T
CENTRAL INDEX KEY: 0001632385
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36828
FILM NUMBER: 151252943
MAIL ADDRESS:
STREET 1: C/O NEXVET BIOPHARMA PLC
STREET 2: NATL INST, FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK
STATE: L2
ZIP: 00000
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-11-23
0001618561
Nexvet Biopharma plc
NVET
0001632385
Farrell Geraldine T
C/O NEXVET BIOPHARMA PLC
UNIT 5, SRAGH TECHNOLOGY PARK,RAHAN ROAD
TULLAMORE , CO. OFFALY
L2
R35 FR98
IRELAND
0
1
0
0
VP Operations, General Counsel
Ordinary Shares
2015-11-23
4
M
0
4300
.125
A
21253
I
By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C>
Ordinary Shares
4300
D
Ordinary Shares
132
I
By Nexvet EBT Limited
Options to purchase shares
.125
2015-11-23
4
M
0
4300
0
D
2019-07-01
Ordinary Shares
4300
5733
I
By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C>
The reporting person and her spouse have shared voting and dispositive power with respect to these reported securities.
The reporting person has sole voting and dispositive power over the reported securities pursuant to that certain Nominee Deed dated as of 11/14/14 by and between Nexvet EBT Limited and the persons named in the schedule thereto. Such Nominee Deed was executed in connection with the Issuer's November 2014 four-for-five share consolidation.
4,300 options to purchase shares vested and became exercisable on 11/19/15 after the Issuer's board of directors determined that there had been successful completion of an efficacy trial for an Issuer product. A further 2,867 options shall vest and become exercisable on 7/1/16, and 2,866 will vest on 7/1/17.
/s/ Geraldine T. Farrell
2015-11-23